Mrs. Carla Smothers Moore, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Bldg 2-3602 Letterman Street, Apo, AA 28310 Phone: 910-396-7951 Fax: 910-907-3048 |
Mrs. Carmen Wilson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6451 Specker Rd Bldg 1830, Apo, AA 80913 Phone: 719-526-5050 |
Ashley Nicole Carrillo, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 761st Tank Bn Ave, Bldg 2255, Apo, AA 76544 Phone: 254-288-6474 |
Erin Mcloud, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 66th Medical Squadron, 90 Vandenberg Bldg 1900, Apo, AA 01731 Phone: 781-225-6264 |
Mrs. April M Yates-blanco, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 36000 Darnall Loop, Apo, AA 76544 Phone: 254-288-8335 |
Diana Meyer, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Scott Afb, Apo, AA 62225 Phone: 618-256-1110 |
Danielle Brandt Anderson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Naval Hospital Guantanamo Bay, Psc 1005 110185, Fpo, AA 34009 Phone: 757-458-2998 |
Mrs. Summer Dawn Feaster, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9040 Reid Street, Attn: Mchj-clq-q, Tacoma, AA 98431 Phone: 253-968-2252 Fax: 253-968-3278 |
News Archive
Colorectal cancer is the second most common type of cancer worldwide, with about 90% of cases occurring in people 50 or older.
NOXXON Pharma AG announced today that it has permission to commence a multiple ascending dose study of its Monocyte Chemoattractant Protein-1 (MCP-1) targeting anti-inflammatory SpiegelmerĀ®, NOX-E36. NOXXON plans to develop NOX-E36 for the treatment of diabetic nephropathy and other diabetes related complications.
A new paper just published in the Journal of Bioethical Inquiry uses extensive Freedom of Information Act findings to detail an extremely troubling off-label medical intervention employed in the U.S. on pregnant women to intentionally engineer the development of their fetuses for sex normalization purposes.
bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE IDĀ®, and the launch of KRAS mutational testing.
Few can tolerate such romantic or professional rebuffs as "It's not you, it's me" and "we regret to inform you that your application was not successful." But while a healthy dose of self-esteem can absorb the shock of rejection, poor self-esteem can trigger the primal fight-or-flight response, according to a new study from the University of California, Berkeley.
› Verified 2 days ago